[1] |
Cona MM, Oyen R, Ni YC. Necrosis avidity of organic compounds: a natural phenomenon with exploitable theragnostic potentials[J]. Curr Med Chem, 2015, 22(15): 1829-1849. doi: 10.2174/0929867322666150227153550
|
[2] |
Galluzzi L, Vitale I, Aaronson SA, et al. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018[J]. Cell Death Differ, 2018, 25(3): 486-541. doi: 10.1038/s41418-017-0012-4
|
[3] |
Zhang DJ, Jiang CH, Feng YB, et al. Molecular imaging of myocardial necrosis: an updated mini-review[J]. J Drug Target, 2020, 28(6): 565-73. doi: 10.1080/1061186X.2020.1725769
|
[4] |
Chen F, Suzuki Y, Nagai N, et al. Rodent stroke induced by photochemical occlusion of proximal middle cerebral artery: evolution monitored with MR imaging and histopathology[J]. Eur J Radiol, 2007, 63(1): 68-75. doi: 10.1016/j.ejrad.2007.01.005
|
[5] |
Hernandez-Martinez JM, Sánchez-Reyes R, De la Garza-Salazar JG, et al. Onco-omics approaches and applications in clinical trials for cancer patients[J]. Adv Exp Med Biol, 2019, 1168: 79-90.
|
[6] |
Smith BA, Smith BD. Biomarkers and molecular probes for cell death imaging and targeted therapeutics[J]. Bioconjug Chem, 2012, 23(10): 1989-2006. doi: 10.1021/bc3003309
|
[7] |
Silvestre-Roig C, de Winther MP, Weber C, et al. Atherosclerotic plaque destabilization: mechanisms, models, and therapeutic strategies[J]. Circ Res, 2014, 114(1): 214-26. doi: 10.1161/CIRCRESAHA.114.302355
|
[8] |
Xie BW, Stammes MA, van Driel PBAA, et al. Necrosis avid near infrared fluorescent cyanines for imaging cell death and their use to monitor therapeutic efficacy in mouse tumor models[J]. Oncotarget, 2015, 6(36): 39036-49. doi: 10.18632/oncotarget.5498
|
[9] |
Stammes MA, Maeda A, Bu JC, et al. The necrosis-avid small molecule HQ4-DTPA as a multimodal imaging agent for monitoring radiation therapy-induced tumor cell death[J]. Front Oncol, 2016, 6: 221.
|
[10] |
Fang C, Wang K, Zeng CT, et al. Illuminating necrosis: from mechanistic exploration to preclinical application using fluorescence molecular imaging with indocyanine green[J]. Sci Rep, 2016, 6: 21013. doi: 10.1038/srep21013
|
[11] |
Yao LP, Xue X, Yu PP, et al. Evans blue dye: a revisit of its applications in biomedicine[J]. Contrast Media Mol Imaging, 2018, 2018: 7628037.
|
[12] |
Miller D L, Li P, Dou C, et al. Evans blue staining of cardiomyocytes induced by myocardial contrast echocardiography in rats: evidence for necrosis instead of apoptosis[J]. Ultrasound Med Biol, 2007, 33(12): 1988-96. doi: 10.1016/j.ultrasmedbio.2007.06.008
|
[13] |
Hamer PW, McGeachie JM, Davies MJ, et al. Evans Blue Dye as an in vivo marker of myofibre damage: optimising parameters for detecting initial myofibre membrane permeability[J]. J Anat, 2002, 200(Pt 1): 69-79.
|
[14] |
Smith SJ, Horstick EJ, Davidson AE, et al. Analysis of zebrafish larvae skeletal muscle integrity with Evans blue dye[J]. J Vis Exp, 2015(105): 53183.
|
[15] |
Feng YB, Chen F, Ma ZL, et al. Towards stratifying ischemic components by cardiac MRI and multifunctional stainings in a rabbit model of myocardial infarction[J]. Theranostics, 2013, 4(1): 24-35.
|
[16] |
Ye, L, Miao X, Chen T, et al. Zebrafish as a visual and dynamic model to study the transport of nanosized drug delivery systems across the biological barriers[J]. Colloids Surf B Biointerfaces, 2017, 156: 227-35. doi: 10.1016/j.colsurfb.2017.05.022
|
[17] |
Gaff DF, Okong'o-Ogola O. The use of non-permeating pigments for testing the survival of cells[J]. J Exp Bot, 1971, 22(3): 756-8. doi: 10.1093/jxb/22.3.756
|
[18] |
Matsuda R, Nishikawa A, Tanaka H. Visualization of dystrophic muscle fibers in mdx mouse by vital staining with Evans blue: evidence of apoptosis in dystrophin-deficient muscle[J]. J Biochem, 1995, 118(5): 959-64. doi: 10.1093/jb/118.5.959
|
[19] |
Li JJ, Cona MM, Chen F, et al. Exploring theranostic potentials of radioiodinated hypericin in rodent necrosis models[J]. Theranostics, 2012, 2(10): 1010-9. doi: 10.7150/thno.4924
|
[20] |
Klyen BR, Sampson DD, Shavlakadze T, et al. Identification of muscle necrosis in the mdx mouse model of Duchenne muscular dystrophy using three-dimensional optical coherence tomography[C]. /2011: 076013.
|
[21] |
Zhang D, Gao M, Jin Q, et al. Updated developments on molecular imaging and therapeutic strategies directed against necrosis[J]. Acta Pharm Sin B, 2019, 9(3): 455-68. doi: 10.1016/j.apsb.2019.02.002
|
[22] |
Jin Q, Shan X, Luo Q, et al. 131I-Evans blue: evaluation of necrosis targeting property and preliminary assessment of the mechanism in animal models[J]. Acta Pharm Sin B, 2018, 8(3): 390-400. doi: 10.1016/j.apsb.2017.08.002
|
[23] |
Waugh TA, Horstick E, Hur J, et al. Fluoxetine prevents dystrophic changes in a zebrafish model of Duchenne muscular dystrophy[J]. Hum Mol Genet, 2014, 23(17): 4651-62. doi: 10.1093/hmg/ddu185
|
[24] |
Yasuda S, Ikuta K, Uwatoku T, et al. In vivo magnetic resonance imaging of atherosclerotic lesions with a newly developed Evans blue-DTPA-gadolinium contrast medium in apolipoprotein-E-deficient mice[J]. J Vasc Res, 2008, 45(2): 123-8. doi: 10.1159/000109930
|
[25] |
Tsopelas C, Bellon M, Bevington E, et al. Lymphatic mapping with 99mTc-Evans Blue dye in sheep[J]. Ann Nucl Med, 2008, 22(9): 777-85. doi: 10.1007/s12149-008-0171-y
|
[26] |
Zang J, Liu QX, Sui HM, et al. Combined 68Ga-NOTA-Evans blue lymphoscintigraphy and 68Ga-NOTA-RM26 PET/CT evaluation of sentinel lymph node metastasis in breast cancer patients[J]. Bioconjug Chem, 2020, 31(2): 396-403. doi: 10.1021/acs.bioconjchem.9b00789
|
[27] |
Hou GZ, Li XQ, Hou B, et al. Lymphangioma on 68Ga-NOTA-Evans blue PET/MRI[J]. Clin Nucl Med, 2018, 43(7): 553-5. doi: 10.1097/RLU.0000000000002129
|
[28] |
Ehlerding EB, Lan XL, Cai WB. "albumin hitchhiking" with an Evans blue analog for cancer theranostics[J]. Theranostics, 2018, 8(3): 812-4. doi: 10.7150/thno.24183
|
[29] |
Zhang JJ, Lang LX, Zhu ZH, et al. Clinical translation of an albumin-binding PET radiotracer 68Ga NEB[J]. J Nucl Med, 2015, 56(10): 1609-14. doi: 10.2967/jnumed.115.159640
|
[30] |
Sutton R, Tsopelas C, Kollias J, et al. Sentinel node biopsy and lymphoscintigraphy with a technetium 99m labeled blue dye in a rabbit model[J]. Surgery, 2002, 131(1): 44-9. doi: 10.1067/msy.2002.118450
|
[31] |
Tsopelas C, Sutton R. Why certain dyes are useful for localizing the sentinel lymph node[J]. J Nucl Med, 2002, 43(10): 1377-82.
|
[32] |
Chen F, Suzuki Y, Nagai N, et al. Rat cerebral ischemia induced with photochemical occlusion of proximal middle cerebral artery: a stroke model for MR imaging research[J]. MAGMA, 2004, 17(3): 103-8.
|